DOI : https://doi.org/10.18517/ijaseit.11.5.15999

No Correlation between Fagerstrom Test for Nicotine Dependence Scores to Lipopolysaccharide Marker in Thai Smokers

Parama Pratummas (1), Phakkharawat Sittiprapaporn (2), Chaiyavat Chaiyasut (3), Sasithorn Sirilun (4), Thamthiwat Nararatwanchai (5)
(1) Neuropsychological Research Laboratory, Department of Anti-Aging and Regenerative Science, School of Anti-Aging and Regenerative Medicine, Mae Fah Luang University, Bangkok 10110, Thailand
(2) Neuropsychological Research Laboratory, Department of Anti-Aging and Regenerative Science, School of Anti-Aging and Regenerative Medicine, Mae Fah Luang University, Bangkok 10110, Thailand
(3) Innovation Centre for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand
(4) Innovation Centre for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand
(5) Department of Anti-Aging and Regenerative Medicine, School of Anti-Aging and Regenerative Medicine, Mae Fah Luang University, Bangkok 10110, Thailand
Fulltext View | Download
How to cite (IJASEIT) :
Pratummas, Parama, et al. “No Correlation Between Fagerstrom Test for Nicotine Dependence Scores to Lipopolysaccharide Marker in Thai Smokers”. International Journal on Advanced Science, Engineering and Information Technology, vol. 11, no. 5, Oct. 2021, pp. 1986-92, doi:10.18517/ijaseit.11.5.15999.
Citation Format :
Cigarette smoking is a combination of thousands of synthetic compounds that contribute straightforwardly or by implication to the addiction of cigarette smoking with inflammation, although a lot more may exist. Genome-wide association studies (GWAS) have unequivocally shown that variety in neuronal nicotinic acetylcholine receptor subunit α5 (CHRNA5) and in cytochrome P450 2A6 (CYP2A6) anticipated smoking substantialness, later period of smoking discontinuance.The relationship between the Fagerstrom Test for Nicotine Dependence and the Lipopolysaccharide marker in Thai smokers was proposed in this study.We investigated fourteen Thai smokers in Mahasarakham province who scored 4 or higher on the Fagerstrom Test for Nicotine Dependence. We provided them surveys about their personal information, administered the Fagerstrom Test for Nicotine Dependence, and continued the Lipopolysaccharide marker blood tests. The value of R in Pearson connection was 0.4438. Although it found a positive correlation, the relationship between Fagerstrom Test for Nicotine Dependence and Lipopolysaccharide level was weak due to no correlation. In addition, the value of R2, the coefficient of determination, was 0.197 (p=0.1119). Further studies are needed to investigate more the relationship between smoking and inflammation.

J. Gauthier, A.T. Vincent, S.J. Charette, and N. Derome, “A brief history of bioinformatics,” Brief Bioinform., vol. 20(6), pp. 1981-1996, 2019. doi: 10.1093/bib/bby063.

R.K. Tiwari, V. Sharma, R.K. Pandey, and S.S. Shukla, “Nicotine Addiction: Neurobiology and Mechanism,” J Pharmacopuncture., vol. 23(1), pp. 1-7, 2020. https://doi.org/10.3831/KPI.2020.23.001.

K. Xu, B. Li, K.A. McGinnis, R. Vickers-Smith, C. Dao, N. Sun, R.L. Kember, H. Zhou, W.C. Becker, J. Gelernter, H.R. Kranzler, H. Zhao, A.C. Justice, and VA Million Veteran Program, “Genome-wide association study of smoking trajectory and meta-analysis of smoking status in 842,000 individuals,” Nat Commun., vol. 11(1), 5302, 2020. https://doi.org/10.1038/s41467-020-18489-3._

L.J. Bierut, and R.F. Tyndale, “Preparing the Way: Exploiting Genomic Medicine to Stop Smoking,” Trends Mol Med., vol. 24(2), pp. 187-196, 2018. https://doi.org/10.1016/j.molmed.2017.12.001.

J.I. de Granda-Orive, J.F. Pascual-Lledó, S. Asensio-Sí¡nchez, S. Solano-Reina, M. da Garcí­a-Rue, M.í. Martí­nez-Muñiz, L. Lí¡zaro-Asegurado, D. Bujulbasich, R. Pendino, S. Luhning, I. Cienfuegos-Agustí­nI, and C.A. Jimí©nez-Ruiz, “Fagerstrí¶m Test and Heaviness Smoking Index. Are they Interchangeable as a Dependence Test for Nicotine?,” Subst Use Misuse., vol. 55(2), pp. 200-208, 2020. https://doi.org/10.1080/10826084.2019.1660680.

B. C. Quach, M. J. Bray, N. C. Gaddis, M. Liu, T. Palviainen, C. C. Minica, S. Zellers, R. Sherva, F. Aliev, M. Nothnagel, K. A. Young, J. A. Marks, H. Young, M. U. Carnes, Y. Guo, A. Waldrop, N. Y. A. Sey, M. T. Landi, D. W. McNeil, D. Drichel, L. A. Farrer, C. A. Markunas, J. M. Vink, J.-J. Hottenga, W. G. Iacono, H. R. Kranzler, N. L. Saccone, M. C. Neale, P. Madden, M. Rietschel, M. L. Marazita, M. McGue, H. Won, G. Winterer, R. Grucza, D. M. Dick, J. Gelernter, N. E. Caporaso, T. B. Baker, D. I. Boomsma, J. Kaprio, J. E. Hokanson, S. Vrieze, L. J. Bierut, E. O. Johnson, and D. B. Hancock, “Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits,” Nat Commun., vol. 11, 5562, 2020. https://doi.org/10.1038/s41467-020-19265-z

S. Papoutsopoulou, J. Satsangi, B.J. Campbell, and C.S. Probert, “Review article: impact of cigarette smoking on intestinal inflammation—direct and indirect mechanisms,” Aliment Pharmacol Ther., vol. 51, pp. 1268- 1285, 2020. https://doi.org/10.1111/apt.15774

L. Mazgaeen, and P. Gurung, “Recent advances in lipopolysaccharide recognition systems,” Int. J. Mol. Sci., vol. 21(2), 379, 2020. https://doi.org/10.3390/ijms21020379

B. Boonen, Y.A. Alpizar, A. Sanchez, A. López-Requena, T. Voets, and K. Talavera, “Differential effects of lipopolysaccharide on mouse sensory TRP channels,” Cell Calcium, vol. 73, pp. 72-81, 2018. https://doi.org/10.1016/j.ceca.2018.04.004.

Y.A. Alpizar, B. Boonen, A. Sanchez, C. Jung, A. López-Requena, R. Naert, B. Steelant, K. Luyts, C. Plata, V.D. Vooght, J.A.J. Vanoirbeek, V.M. Meseguer, T. Voets, J.L. Alvarez, P.W. Hellings, P.H.M. Hoet, B. Nemery, M.A. Valverde, and K. Talavera, “TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells,” Nat Commun., vol. 8, 1059, 2017. https://doi.org/10.1038/s41467-017-01201-3

L. Salhi, L. Seidel, A. Albert, and F. Lambert, “Fagerstrí¶m test for nicotine dependence as an indicator in tobacco-related studies in periodontology,” J Periodontol., vol. 92(2), pp. 298-305, 2021. https://doi.org/10.1002/JPER.20-0019.

N.L. Saccone, J.W. Baurley, A.W. Bergen, S.P. David, H.R. Elliott, M.G. Foreman, J. Kaprio, T.M. Piasecki, C.L. Relton, L. Zawertailo, L.J. Bierut, R.F. Tyndale, L.S. Chen, and Genetics and Treatment Networks of the Society for Research on Nicotine and Tobacco (SRNT), “The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings,” Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, vol. 20(4), pp. 403-413, 2018. https://doi.org/10.1093/ntr/ntx096

L.J. Bierut, “Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation,” Nicotine Tob Res., vol. 22(2), pp. 147-151, 2020. https://doi.org/10.1093/ntr/ntz036.

C.L. Mota, S. Mitri, C. Barata-Silva, and J.C. Moreira, “CHRNA5/CHRNA3 polymorphisms and tobacco smoking risk in a Brazilian population sample,” GSC Biol. Pharm. Sci., vol. 12(2), pp. 143-152, 2020. https://doi.org/10.30574/gscbps.2020.12.2.0253

Y.L. Strat, N. Ramoz, and P. Gorwood, “Evidence for the association of the nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster and nicotine dependence in a young population of students,” French J. Psychiatry, vol. 6898(100), pp. S1-S182, 2020. http://dx.doi.org/10.1016/j.fjpsy.2020.09.001

E.D. Coverstone, R.G. Bach, L. Chen, L.J. Bierut, A.Y. Li, P.A. Lenzini, H.C. O'Neill, J.A. Spertus, C.C. Sucharov, J.A. Stitzel, J.D. Schilling, and S. Cresci, “A novel genetic marker of decreased inflammation and improved survival after acute myocardial infarction,”. Basic Res Cardiol., vol. 113(5), 38, 2018. https://doi.org/10.1007/s00395-018-0697-7.

J. Dai, M. Huang, C.I. Amos, R.J. Hung, A. Tardon, A. Andrew, C. Chen, D.C. Christiani, D. Albanes, G. Rennert, J. Fan, G. Goodman, G. Liu, J.K. Field, K. Grankvist, L.A. Kiemeney, L. Le Marchand, M.B. Schabath, M. Johansson, M.C. Aldrich, M. Johansson, N. Caporaso, P. Lazarus, S. Lam, S.E. Bojesen, S. Arnold, M.T. Landi, A. Risch, H.E. Wichmann, H. Bickeboller, P. Brennan, S. Shete, O. Melander, H. Brunnstrom, S. Zienolddiny, P. Woll, V. Stevens, Z. Hu, and H. Shen, “Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk,” Int J Cancer., vol. 146(10), pp. 2855-2864, 2020. doi: 10.1002/ijc.32698.

A. Dutkowska, B. Szmyd, M. Kaszkowiak, and D. Daria DomaÅ„ska-Senderowska, D. Pastuszak-Lewandoska, E. BrzeziaÅ„ska-Lasota, J. Kordiak, and A. Antczak, “Expression of inflammatory interleukins and selected miRNAs in non-small cell lung cancer,” Sci Rep., vol. 11, 5092, 2021. https://doi.org/10.1038/s41598-021-84408-1

R.L. Papke, D.H. Brunzell, and M. De Biasi, “Cholinergic Receptors and Addiction. Curr Top Behav Neurosci., vol. 45, pp. 123-151, 2020. https://doi.org/10.1007/7854_2020_139.

A. Jackson, D. Bagdas, P.P. Muldoon, A.H. Lichtman, F.I. Carroll, M. Greenwald, M.F. Miles, and M.I. Damaj, “In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence. Neuropharmacology, vol. 15(118), pp. 38-45, 2017. https://doi.org/10.1016/j.neuropharm.2017.03.005.

R.M. Schuster, G.N. Pachas, L. Stoeckel, C. Cather, M. Nadal, D. Mischoulon, D.A. Schoenfeld, H. Zhang, C. Ulysse, E.B. Dodds, S. Sobolewski, V. Hudziak, A. Hanly, M. Fava, and A.E. Evins, “Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence,” J Clin Psychopharmacol., vol. 38(4), pp. 307-316, 2018. https://doi.org/10.1097/JCP.0000000000000919.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).